We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Monday
May 18
15:15 - 16:15
T2
Gastrointestinal cancers 2
Camilla Kronborg, Denmark;
Clair Brunner, United Kingdom
Mini-Orals
Clinical
15:15 - 16:15
The impact of age and sex on quality of life and oncological outcomes in patients with locally advanced rectal cancer undergoing TNT
Markus Diefenhardt, Germany
-2309
15:15 - 16:15
Early determination of tumor response to neoadjuvant chemotherapy alone without radiation for locally advanced rectal Cancer
Ziqiang Wang, China
-350
15:15 - 16:15
Five-year Results of the OPERA Trial: When and How to Assess Tumor Response to Guide Rectal Preservation
Syrine Ben Dhia, France
-3371
15:15 - 16:15
Acute toxicity and compliance using involved field and pelvic IMRT in anal squamous cell carcinoma: data from the PLATO ACT3 and ACT 4 clinical trials
Rebecca Muirhead, United Kingdom
-3977
15:15 - 16:15
Radiation-induced lymphopenia during neoadjuvant chemoradiotherapy as predictive biomarker for nivolumab benefit in esophageal cancer
Peter van Rossum, The Netherlands
-4899
15:15 - 16:15
Immunomodulatory effects of SBRT with or without concomitant systemic treatment in metastatic liver disease: Results from the prospective LAPIS study
Eleni Gkika, Germany
-4684
15:15 - 16:15
Multi-institutional clinical outcomes of ablative MR-guided radiotherapy for inoperable pancreatic ductal adenocarcinoma
Mohamed Schumann, Germany
-4945
15:15 - 16:15
Multidisciplinary Delphi consensus on the use of image-guided radiotherapy for upper gastrointestinal tumours: an AIRO–AITRO–AIFM study
Elena Galofaro, Italy
-3843